Valuation: GENFIT

Market Cap 455M 512M 425M 387M 730M 49.25B 737M 5.14B 1.99B 25.18B 1.92B 1.88B 80.81B P/E 2026 *
35.2x
P/E 2027 * 97.3x
Enterprise Value 404M 455M 377M 344M 648M 43.72B 654M 4.56B 1.77B 22.35B 1.71B 1.67B 71.74B EV / Sales 2026 *
4.31x
EV / Sales 2027 * 2.98x
Free-Float
86.89%
Yield 2026 *
-
Yield 2027 * -
1 day-3.60%
1 week+2.02%
Current month-8.27%
1 month-36.10%
3 months-13.99%
6 months+5.45%
Current year+72.84%
1 week 8.85
Extreme 8.85
10.26
1 month 8.66
Extreme 8.66
14.5
Current year 5.05
Extreme 5.05
15.48
1 year 3.34
Extreme 3.34
15.48
3 years 2.62
Extreme 2.62
15.48
5 years 2.62
Extreme 2.62
15.48
10 years 2.62
Extreme 2.62
35.65
Manager TitleAgeSince
Chief Executive Officer 58 16/09/2019
Director of Finance/CFO 52 22/04/2021
Chief Tech/Sci/R&D Officer - 27/11/2025
Director TitleAgeSince
Chairman 70 16/06/2017
Director/Board Member 54 15/09/1999
Director/Board Member 58 16/06/2017
Date Insider Type Main position Quantity % Market Cap. Importance
5/3/26 Exercice

Chief Operating Officer

11,250 0.0225%
5/3/26 Exercice

Chief Operating Officer

7,083 0.0142%
5/3/26 Sell

Chief Operating Officer

7,083 0.0142%
Change 5-day change 1-year change 3-year change Capi.($)
-3.60%+2.02%+160.00%+202.33% 512M
+4.16%+3.04%+49.37%+94.17% 74.16B
-3.11%-3.53%+21.92%+74.60% 57.39B
+0.89%-0.63%+4.28%+34.51% 47.64B
+0.36%+0.81%+352.17%+689.61% 44.29B
-0.96%-4.50%+26.36%+33.18% 42.5B
-0.20%-0.77%+3.74%+100.60% 40.71B
-0.54%+2.93%+9.31%+50.41% 30.97B
-2.68%+2.92%+29.63%+19.50% 28.53B
+0.05%-1.64%-7.28%-14.06% 24.34B
Average -0.56%-0.33%+64.95%+128.48% 39.1B
Weighted average by Cap. +0.12%-0.84%+58.90%+130.00%

Financials

2026 *2027 *
Net sales 93.77M 106M 87.52M 79.77M 150M 10.15B 152M 1.06B 410M 5.19B 396M 388M 16.65B 130M 146M 121M 110M 208M 14.05B 210M 1.47B 568M 7.18B 549M 537M 23.05B
Net income 18.4M 20.71M 17.18M 15.66M 29.53M 1.99B 29.8M 208M 80.55M 1.02B 77.76M 76.08M 3.27B 10.37M 11.67M 9.68M 8.82M 16.63M 1.12B 16.79M 117M 45.37M 573M 43.81M 42.86M 1.84B
Net Debt -51.11M -57.52M -47.7M -43.48M -82M -5.53B -82.76M -577M -224M -2.83B -216M -211M -9.07B -67.56M -76.04M -63.05M -57.47M -108M -7.31B -109M -763M -296M -3.74B -285M -279M -11.99B
Logo GENFIT
GENFIT is a biopharmaceutical company in late-stage development focused on the discovery and development of innovative therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, in particular due to a lack of approved treatments. GENFIT is a leading innovator in the field of nuclear receptor-based drug discovery with a rich history and a solid scientific heritage spanning nearly two decades. The company has offices in Lille, Paris, Zurich and Cambridge, MA (USA).
Employees
161
Date Price Change Volume
02/10/26 EUR 9.100 -3.60% 287,895
01/10/26 EUR 9.440 -4.84% 402,120
30/09/26 EUR 9.920 +4.64% 504,124
29/09/26 EUR 9.480 -3.66% 976,061
28/09/26 EUR 9.840 +10.31% 1,055,339
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
9.100EUR
Average target price
17.48EUR
Spread / Average Target
+92.09%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GNFT Stock